- UroToday Home
- Recent Abstracts
- Urologic Oncology
Prostate Cancer
Robust plan optimization for electromagnetic transponder guided hypo-fractionated prostate treatment using volumetric modulated arc therapy - Abstract
November 18, 2013
Cancer-associated bone disease - Abstract
November 18, 2013
Algeta ASA: Xofigo® (radium Ra 223 dichloride) granted marketing authorization in the European Union
November 15, 2013
Prognostic model predicting metastatic castration-resistant prostate cancer survival in men treated with second-line chemotherapy - Abstract
November 15, 2013
Post-radical prostatectomy predictive factors for biochemical recurrence - Abstract
November 15, 2013
Diagnosis and multimodal therapy for extragastrointestinal stromal tumor of the prostate: A case report - Abstract
November 15, 2013
Complete regression of advanced prostate cancer for ten years: A case report and review of the literature - Abstract
November 15, 2013
An assessment of PTV margin based on actual accumulated dose for prostate cancer radiotherapy - Abstract
November 15, 2013
Evaluation of safety and analgesic consumption in patients with advanced cancer treated with zoledronic acid - Abstract
November 14, 2013
"N of 1" case reports in the era of whole-genome sequencing - Abstract
November 14, 2013
Toxicity and efficacy of three dose-fractionation regimens of intensity-modulated radiation therapy for localized prostate cancer - Abstract
November 14, 2013
A prospective pilot study of 89Zr-J591/PSMA positron emission tomography (PET) in men with localized prostate cancer undergoing radical prostatectomy - Abstract
November 14, 2013
18F-FACBC compared with 11C-choline PET/CT in patients with biochemical relapse after radical prostatectomy: A prospective study in 28 patients - Abstract
November 14, 2013
Diffuse osteosclerosis in a patient with prostate cancer - Abstract
November 14, 2013